We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Benson Hill Biosystems Stock

Invest in or calculate the value of your shares in Benson Hill Biosystems or other pre-IPO companies through EquityZen's platform.

Get Started

Benson Hill Biosystems Stock

Agricultural biotechnology company focused on the development of traits to increase intrinsic crop yield

About Benson Hill Biosystems Stock

Founded

2012

Headquarters

Raleigh, NC, US

Total Funding

94.7M

Industries

Software, Artificial Intelligence, Data and Analytics

According to the company, boosting crop yields on existing acreage and with limited inputs is the foremost challenge in sustainable production agriculture. With the global population projected to reach nine billion by 2050, agricultural output must increase by 70% in this timeframe. As nations such as the United States pursue agriculture-intensive energy policies, demand and price volatility for agriculture commodities will continue to intensify. Diminishing agricultural resources such as arable land and fresh water will further compound this challenge. In the last twenty years, crop yields have improved from intensive breeding programs, increased planting densities, and biotech traits such as insect resistance and herbicide tolerance. However, blockbuster trait releases in recent years are only having single digit percentage impacts on yield. At a time when step changes are needed in crop productivity, yields are plateauing. One contributing factor to the decline in crop development is that nearly all commercial biotech traits are single-gene approaches to protecting yield. But to realize step changes and avoid a yield plateau, the company believes the industry must innovate beyond single-gene approaches to protecting yield, and realize step wise gains by increasing intrinsic yield. Benson Hill states that it is dedicated to delivering substantial production gains to the agriculture sector by advancing biotech-based traits to increase intrinsic yield.

Benson Hill Biosystems Management

Leadership team at Benson Hill Biosystems

Founder, President & CEO

Matthew B. Crisp

CTO

Todd C. Mockler

Locked Features

Join now and verify your accreditation status to gain access to:

  • Benson Hill Biosystems current valuation
  • Benson Hill Biosystems stock price
  • Available deals in Benson Hill Biosystems and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Benson Hill Biosystems Stock

How to invest in Benson Hill Biosystems stock?

Accredited investors can buy pre-IPO stock in companies like Benson Hill Biosystems through EquityZen funds. These investments are made available by existing Benson Hill Biosystems shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Benson Hill Biosystems stock?

Shareholders can sell their Benson Hill Biosystems stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."